BACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count increment and the hemoglobin increment, respectively, 24 h after transfusion in 105 patients who received HSCT. METHODOLOGY/PRINCIPAL FINDINGS: Using retrospective analysis, we studied whether factors, including gender, time of transplantation, the compatibility of ABO group between HSC donors and recipients, and autologous or allogenic transplantation, influence the efficacy of blood component transfusion. We found that the infection rate of HSCT ...
Introduction: Transfusion of blood products, especially red blood cells (RBC) is the most common med...
Autologous peripheral blood stem cells transplantation (PBSCT) is a therapeutic option which can be ...
Sergio Parco, Fulvia VascottoInstitute for Maternal and Child Health – IRCCS Burlo Garofol...
Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoi...
Background: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patie...
Background: Autologous hematopoietic stem cell transplantation (auto-HSCT) has become an effective t...
Abstract Background Insight regarding transfusion pra...
BACKGROUND: Providing patients with platelet (PLT) transfusions requires important logistic resource...
AbstractAn optimal platelet-count threshold for prophylactic platelet transfusion in hematopoietic s...
Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) always require platele...
Allogeneic hematopoietic cell transplantation (HCT) recipients have substantial transfusion requirem...
Background: CD34+ cells infused predicts myeloid and platelet engraftment at the time of autologous ...
Significant research has focused individually on blood donors, product preparation and storage, and ...
Background and objective: Haematopoietic stem cell transplant is a potentially curative treatment op...
Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) always require platele...
Introduction: Transfusion of blood products, especially red blood cells (RBC) is the most common med...
Autologous peripheral blood stem cells transplantation (PBSCT) is a therapeutic option which can be ...
Sergio Parco, Fulvia VascottoInstitute for Maternal and Child Health – IRCCS Burlo Garofol...
Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoi...
Background: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patie...
Background: Autologous hematopoietic stem cell transplantation (auto-HSCT) has become an effective t...
Abstract Background Insight regarding transfusion pra...
BACKGROUND: Providing patients with platelet (PLT) transfusions requires important logistic resource...
AbstractAn optimal platelet-count threshold for prophylactic platelet transfusion in hematopoietic s...
Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) always require platele...
Allogeneic hematopoietic cell transplantation (HCT) recipients have substantial transfusion requirem...
Background: CD34+ cells infused predicts myeloid and platelet engraftment at the time of autologous ...
Significant research has focused individually on blood donors, product preparation and storage, and ...
Background and objective: Haematopoietic stem cell transplant is a potentially curative treatment op...
Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) always require platele...
Introduction: Transfusion of blood products, especially red blood cells (RBC) is the most common med...
Autologous peripheral blood stem cells transplantation (PBSCT) is a therapeutic option which can be ...
Sergio Parco, Fulvia VascottoInstitute for Maternal and Child Health – IRCCS Burlo Garofol...